Journal of Vaccines & Vaccination

3^rd International Conference on Vaccines & Vaccination

July 29-31, 2013 Embassy Suites Las Vegas, NV, USA

Accepted Abstracts

• Safety and potency test for experimental cell culture based anti-rabies vaccine produced in Ethiopia

  Abebe Mengesha, Newayeselassie B, Hurrisa B, Beyene M, Denis B, Artem M, Kerga S and Urga K

  PDF HTML

• A comparison of effect of new formulation antigen on Th1 & Th2 cytokine profiles, and, their relationship with spleen' white pulp size expansion in balb/c mice, post challenging with Leishmania major

  Afshineh Latifynia, A. Khamesipour, Gharagozlou M. J., Mohebali M., Hajaran H. and N. Khansari

  PDF HTML

• Chitosan as an adjuvant for preparation of inactivated influenza vaccine

  I. Khalili, M. Fathi Najafi and S. Avagyan

  PDF HTML

• Immunogenicity and protective efficacy of multi-serotype outer membrane vesicles of shigellae in animal model

  Hemanta Koley and Soma Mitra

  PDF HTML

• Combining next-generation sequencing and protein design-A systematic approach to vaccine development

  Jiang Zhu

  PDF HTML

• Eight segment swine influenza virus containing H1 and H3 Hemagglutinins as a candidate for novel vaccine in pigs

  Aleksandar Masic, Hyun-Mi Pyo, Shawn Babiuk and Yan Zhou

  PDF HTML

• Pathological observation of DNA vaccines on mice infected with multi-drug-resistant Mycobacterium tuberculosis

  Yu Qi, Bai Xuejuan and Lining

  PDF HTML

• Antibodies by non-febrile, smear-negative individuals from a malaria epidemic setting in Ethiopia are reactive to Plasmodium falciparum blood-stage-vaccine candidate antigens

  Hassen Mamo

  PDF HTML

• Assessment of antibody titers and immunity to Hepatitis B in children after chemotherapy

  Ali Shams, Faeze Salehi, Azam Hashemi, Mahmood Vakili, Fateme Zare and Nasrin Esphandyari

  PDF HTML

• Socioeconomic status of women and immunization status of under five children in northern Nigeria: A case study of poliomyelitis in Kaduna State

  Oladipo Aina

  PDF HTML

• Determination of Toxoplasma gondii parasitic load in balb/c mice immunized with ESA of RH strain using real time Q-PCR

  Ahmad Daryani, Yousef Dadimoghaddam, Mehdi Sharif, Mohammad Bagher Hashemi, Hamed Kalani, Shabeddin Sarvi, Hajar Ziaei, Alireza Khalilian and Ehsan Ahmadpour

  PDF HTML

• Strategic analysis of the European vaccines market for infectious diseases - understanding the quantitative aspects and leveraging growth opportunities for vaccines manufacturers

  Aiswariya Chidambaram

  PDF HTML

• Protection from H1N1 influenza virus challenge with a single dose HA subunit protein vaccine

  Alison McCormick, Jyothi Mallajosuyla, Trushar Jeevan, Richard Webby, Ernie Hiatt and Gregory Pogue

  PDF HTML

• Safety and immunogenicity of ETHIORAB rabies vaccine

  Birhanu Hurisa, Belete Tegbaru, Dagmar Nolkes, Abebe Mengesha, Sisay Kerga, Gezahegn Kebede, Amdemicael Adhanom, Alemayehu Godana, Dereje Nigussie, Gashew Gabrewold, Denis Bankovisky, Arthem Metlin and Kelbessa Urga

  PDF HTML

• Multiple peptide antigen (MAP) approach for V antigen of Y. pestis as a vaccine candidate

  D. N. Rao

  PDF HTML

• Evaluating DNA vaccine encoding GRA5 antigen of Toxoplasma gondii in BALB/c mice

  Ghaffarifar F, Naserifar R, Dalimi A and Sharifi Z

  PDF HTML

• Is a Herpes vaccine possible? Setting up the road for next generation of herpes vaccines

  Lbachir BenMohamed and Tiffany Kuo

  PDF HTML

• Influence of neonatal BCG vaccination and environmental mycobacteria in sensitizing the anti-mycobacterial activity of macrophages

  Mathan Periasamy, Manjula Datta, M. Kannapiran, V.D. Ramanathan and Perumal Venkatesan

  PDF HTML

• Laser-based vaccine adjuvant and delivery

  Mei X. Wu, Ji Wang, Xinyuan Chen, Dilip K. Shah and Richard R. Anderson

  PDF HTML

• Live attenuated varicella vaccine: A new effective adjuvant weapon in the battlefield against severe resistant psoriasis, a randomized controlled trial

  Rania Abdel Hay

  PDF HTML

• T-cell responsiveness to myelin sheath proteins (MSP)-derived peptides in multiple sclerosis patients of different disease types for a randomized, double-blind T cell vaccination clinical trial

  Rivka Abulafia-Lapid

  PDF HTML

• Drinking water and sanitation status in Ethiopia: A literature survey

  Samuel Teshome

  PDF HTML

• Mutation patterns in P. falciparum and P. knowlesi marker genes associated with drug resistance show discordance among mixed infection cases

  Yagya D. Sharma, Rupesh K. Tyagi, Manoj K. Das and Shiv S. Singh

  PDF HTML

• Production of nano-dendrimer containing HPV E 16d candidate vaccine and evaluation of its immune responses in laboratory murine model

  Atefeh Shahbazi

  PDF HTML

• Production of cell culture based anti-rabies vaccine in Ethiopia

  Birhanu Hurisa, Abebe Mengesha, Bethlehem Newayesilassie, Sisay Kerga, Gezahegn Kebede, Denis Bankovisky, Arthem Metlin and Kelbessa Urga

  PDF HTML

• Birhanu Hurisa1, Abebe Mengesha1, Bethlehem Newayesilassie1, Sisay Kerga1, Gezahegn Kebede1, Denis Bankovisky2, Arthem Metlin3 and Kelbessa Urga1

  Carina S. Pinheiro, Vicente P. Martins, Barbara C. P. Figueiredo, Natan R. G. Assis, Suellen B. Morais, Marcelo V. Caliari,Vasco Azevedo, WilliamCastro-Borges, R. AlanWilson and Sergio C. Oliveira

  PDF HTML

• Immunogenicity and protective efficacy of oral heat-killed multi-serotype Shigella (HKMS) vaccine in rabbit model

  Dhrubajyoti Nag

  PDF HTML

• Determinants of uptake of third doses of oral polio and diphtheria-pertussis-tetanus vaccines in Ibadan north local government area, Nigeria

  Emem Emmanuel Etukiren and Akinola Ayoola Fatiregun

  PDF HTML

• Factors associated with complete immunization coverage in children aged 12-23 months in Ambo Woreda, Central Ethiopia

  Belachew Etana and Wakgari Deressa

  PDF HTML

• Construction and characterization of an acapsular mutant of Pasteurella multocida strain P-1059 (A:3)

  Entomack Borrathybay, Yu-Feng Zhang, Wulumuhan Nazierbieke and Feng-Juan Gong

  PDF HTML

• Immune response to toxoplasma gondii by SAG1 encoded DNA vaccine

  Fatemeh Ghaffarifar, Fariba Khoshzaban, Zohreh Sharifi, Kavous Solhjou, Abdolhossein Dalimi, Ghazal Shahpari and Salimeh Ghaffarifar

  PDF HTML

• Nanochelating technology introduces a new generation of efficient adjuvants

  Mohammad Hassan Nazaran, Saideh Fakharzadeh, Somayeh Kalanaky, Maryam Hafizi, Mohammad Mahdi Goya, Zahra Masoumi, Maryam Abbasi and Mehdi Mahdavi

  PDF HTML

• Comparison of tuberculin skin test (TST) and quantiferon test (QFT) for detection of latent TB infection among health care workers (HCWs) in a tertiary care hospital in Riyadh, Saudi Arabia

  Moustafa A. F. Abbas2, Nasser AE. AIHamdan1, Mohamed S. AIQahtani, Suhail Klantan, Lamiaa A. Fiala and Gehad ElGhazali

  PDF HTML

• A review on generation of novel human cancer vaccines testing in phase III clinical trials

  Parth B. Patel

  PDF HTML

• Development of edible vaccine against anthrax by using edema factor gene of Bacillus anthracis

  Prerna Chaudhary

  PDF HTML

• Increasing incidence of hepatitis A in Lebanese adults: Call for a vaccine strategy

  Sami Ramia

  PDF HTML

• A study on prevalence of vaccine preventable diseases in children of 2-15 years due to fallout from vaccination schedule

  Sandeepkumar R. Chauhan, Arohi Chauhan and Aparajita Shukla

  PDF HTML

• HSP70 mediated multi-epitope DNA as vaccine candidate for Newcastle disease of poultry

  Satish Gaikwad, Sohini Dey, R. Saravanan, Nitin M. Kamble, Aravind S. Pillai and C. Madhan Mohan

  PDF HTML

• HPV vaccination in ARV-treated HIV-infected adolescents and young adults induces strong HPV-specific cell-mediated immune responses

  Veronica Rainone, Daria Trabattoni, Francesca Penagini, Francesca Dinello, Gian Vincenzo Zuccotti, Vania Giacomet, Alessandra Vigano and Mario Clerici

  PDF HTML

• Efficacy study of a therapeutic human papillomavirus (type-16) vaccine (a recombinant HPV16 L2E6E7 fusion protein) in mouse and macaque experiments

  Wu Jie, Chen Gang, Jin Su-feng, Gao Men, Jiang Yun-shui, Li Jian-buo, Zhuang Fang-cheng, Zhao Li, Mao Zian and Tian Houwen

  PDF HTML